ARTICLE | Company News
Medarex, Diatos SA deal
April 3, 2006 7:00 AM UTC
MEDX granted Diatos full European commercialization rights to DTS-201, a doxorubicin prodrug to treat cancer. MEDX will receive an upfront payment in cash and stock and is eligible for milestones and ...